RCUS insider transaction filings
Arcus Biosciences, Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-13. Screen RCUS transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-13 | 4 | Jaen Juan C. — President | Sale (S): 48,502 @ $30.05 · Sale (S): 19,799 @ $28.61 · Sale (S): 268 @ $29.40 | EDGAR |
| 2026-06-24 | 4 | Jaen Juan C. — President | Sale (S): 9,236 @ $27.03 · Sale (S): 14,067 @ $27.69 · Sale (S): 1,697 @ $28.06 · Sale (S): 6,431 @ $29.66 | EDGAR |
| 2026-06-12 | 4 | Tang Carolyn C. — General Counsel | Option exercise (M): 34,090 @ $2.57 · Option exercise (M): 34,090 (derivative) @ $2.57 | EDGAR |
| 2026-06-12 | 4 | Ribas Antoni — Director | Grant/award (A): 5,700 @ $0 · Grant/award (A): 16,900 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | Lambert Nicole — Director | Grant/award (A): 5,700 @ $0 · Grant/award (A): 16,900 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | Lacey David L. — Director | Grant/award (A): 5,700 @ $0 · Grant/award (A): 16,900 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | Machado Patrick — Director | Grant/award (A): 5,700 @ $0 · Grant/award (A): 16,900 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | KANEKO YASUNORI — Director | Grant/award (A): 5,700 @ $0 · Grant/award (A): 16,900 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | FALBERG KATHRYN E — Director | Grant/award (A): 5,700 @ $0 · Grant/award (A): 16,900 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | PERLMAN ANDREW J — Director | Grant/award (A): 5,700 @ $0 · Grant/award (A): 16,900 (derivative) @ $0 | EDGAR |
| 2026-06-01 | 4 | Azoy Alexander — Chief Accounting Officer | Sale (S): 2,562 @ $25.77 | EDGAR |
| 2026-05-12 | 4 | Ribas Antoni — Director | Gift (G): 5,050 @ $0 | EDGAR |
| 2026-05-12 | 4 | Goeltz II Robert C. — Chief Financial Officer | Sale (S): 7,763 @ $25.63 | EDGAR |
| 2026-01-26 | 4 | Markus Richard — Chief Medical Officer | Grant/award (A): 24,000 @ $0 · Grant/award (A): 96,000 (derivative) @ $0 | EDGAR |
| 2026-01-26 | 4 | Tang Carolyn C. — General Counsel | Grant/award (A): 24,000 @ $0 · Grant/award (A): 96,000 (derivative) @ $0 | EDGAR |
| 2026-01-26 | 4 | Azoy Alexander — Chief Accounting Officer | Grant/award (A): 21,050 @ $0 · Grant/award (A): 14,050 (derivative) @ $0 | EDGAR |
| 2026-01-26 | 4 | Jarrett Jennifer — Chief Operating Officer | Grant/award (A): 31,000 @ $0 · Grant/award (A): 126,000 (derivative) @ $0 | EDGAR |
| 2026-01-26 | 4 | Goeltz II Robert C. — Chief Financial Officer | Grant/award (A): 24,000 @ $0 · Grant/award (A): 96,000 (derivative) @ $0 | EDGAR |
| 2026-01-26 | 4 | Jaen Juan C. — President | Grant/award (A): 31,000 @ $0 · Grant/award (A): 126,000 (derivative) @ $0 | EDGAR |
| 2026-01-26 | 4 | ROSEN TERRY J — Chief Executive Officer, Director | Grant/award (A): 79,000 @ $0 · Grant/award (A): 315,000 (derivative) @ $0 | EDGAR |
| 2026-01-09 | 4 | ROSEN TERRY J — Chief Executive Officer, Director | Gift (G): 35,000 @ $0 | EDGAR |
| 2026-01-07 | 4 | Jaen Juan C. — President | Sale (S): 29,670 @ $21.34 · Sale (S): 2,053 @ $22.34 · Sale (S): 100 @ $23.20 | EDGAR |
| 2026-01-02 | 4 | Goeltz II Robert C. — Chief Financial Officer | Sale (S): 6,552 @ $23.38 | EDGAR |
| 2026-01-02 | 4 | ROSEN TERRY J — Chief Executive Officer, Director | Gift (G): 2,400 @ $0 | EDGAR |
| 2025-12-18 | 4 | Markus Richard — Chief Medical Officer | Sale (S): 5,052 @ $21.88 · Sale (S): 4,494 @ $22.16 | EDGAR |
| 2025-12-18 | 4 | Tang Carolyn C. — General Counsel | Sale (S): 7,658 @ $21.88 · Sale (S): 6,810 @ $22.16 | EDGAR |
| 2025-12-18 | 4 | Azoy Alexander — Chief Accounting Officer | Sale (S): 2,376 @ $21.88 · Sale (S): 2,113 @ $22.16 · Sale (S): 4,343 @ $22.25 | EDGAR |
| 2025-12-18 | 4 | Jarrett Jennifer — Chief Operating Officer | Sale (S): 11,225 @ $21.88 · Sale (S): 9,983 @ $22.16 | EDGAR |
| 2025-12-18 | 4 | Goeltz II Robert C. — Chief Financial Officer | Sale (S): 6,702 @ $21.88 · Sale (S): 5,960 @ $22.16 | EDGAR |
| 2025-12-18 | 4 | Jaen Juan C. — President | Sale (S): 11,225 @ $21.88 · Sale (S): 9,983 @ $22.16 | EDGAR |
| 2025-12-18 | 4 | ROSEN TERRY J — Chief Executive Officer, Director | Sale (S): 28,947 @ $21.88 · Sale (S): 25,744 @ $22.16 | EDGAR |
| 2025-12-05 | 4 | Jaen Juan C. — President | Sale (S): 82,997 @ $24.71 | EDGAR |
| 2025-12-01 | 4 | Azoy Alexander — Chief Accounting Officer | Option exercise (M): 1,900 @ $13.33 · Sale (S): 1,900 @ $26 · Option exercise (M): 1,900 (derivative) @ $0 | EDGAR |
| 2025-11-26 | 4 | Goeltz II Robert C. — Chief Financial Officer | Sale (S): 5,000 @ $25 | EDGAR |
| 2025-11-19 | 4 | Jaen Juan C. — President | Sale (S): 37,114 @ $20.23 · Sale (S): 7,836 @ $20.71 · Sale (S): 5,050 @ $19.75 | EDGAR |
| 2025-11-12 | 4 | Jarrett Jennifer — Chief Operating Officer | Option exercise (M): 50,291 @ $1.23 · Sale (S): 50,291 @ $18.97 · Option exercise (M): 50,291 (derivative) @ $1.23 | EDGAR |
| 2025-11-03 | 4 | Jaen Juan C. — President | Sale (S): 4,314 @ $20.32 | EDGAR |
| 2025-10-30 | 4 | Jaen Juan C. — President | Sale (S): 19,019 @ $20.19 · Sale (S): 47,675 @ $20.49 · Sale (S): 29,365 @ $21.53 · Sale (S): 800 @ $22.04 | EDGAR |
| 2025-10-29 | 4 | Goeltz II Robert C. — Chief Financial Officer | Sale (S): 5,000 @ $20 | EDGAR |
| 2025-10-08 | 4 | Jarrett Jennifer — Chief Operating Officer | Option exercise (M): 12,500 @ $1.23 · Sale (S): 12,500 @ $14.54 · Option exercise (M): 37,792 @ $1.23 · Sale (S): 37,792 @ $15.05 · Option exercise (M): 12,500 (derivative) @ $0 · Option exercise (M): 37,792 (derivative) @ $0 | EDGAR |
| 2025-09-30 | 4 | Azoy Alexander — Chief Accounting Officer | Sale (S): 2,831 @ $13 | EDGAR |
| 2025-09-05 | 4 | Azoy Alexander — Chief Accounting Officer | Sale (S): 1,579 @ $11.88 | EDGAR |
| 2025-06-12 | 4 | Ribas Antoni — Director | Grant/award (A): 13,300 @ $0 · Grant/award (A): 38,300 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | Lacey David L. — Director | Grant/award (A): 13,300 @ $0 · Grant/award (A): 38,300 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | Lambert Nicole — Director | Grant/award (A): 13,300 @ $0 · Grant/award (A): 38,300 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | Machado Patrick — Director | Grant/award (A): 13,300 @ $0 · Grant/award (A): 38,300 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | KANEKO YASUNORI — Director | Grant/award (A): 13,300 @ $0 · Grant/award (A): 38,300 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | FALBERG KATHRYN E — Director | Grant/award (A): 13,300 @ $0 · Grant/award (A): 38,300 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | PERLMAN ANDREW J — Director | Grant/award (A): 13,300 @ $0 · Grant/award (A): 38,300 (derivative) @ $0 | EDGAR |
| 2025-02-27 | 4 | KANEKO YASUNORI — Director | Purchase (P): 20,000 @ $10.06 | EDGAR |
Recent 8-K events — Arcus Biosciences, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-05 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-12 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-05 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-20 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-03-23 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-02-25 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-18 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant | EDGAR |
| 2025-12-12 | 8-K | 8.01 — Other Events | EDGAR |
| 2025-11-03 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-28 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=RCUS returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →